One way to assess stock values is to compare the stock’s share price with its asset value.
The latter is the number of shares outstanding divided into total assets. When the result is compared with share prices, it can help investors decide whether a stock is over- or under-valued.
We took a look at the asset values for 15 of the world’s largest pure-play medical device companies and then compared them with the companies’ stock price.
Want more data? Download the 2012 MassDevice Big 100
It’s no surprise that, with shares trading well north of $400, that Intuitive Surgical (NSDQ:ISRG) shows a gap of nearly $387 between its share price at the end of last year and its asset value. It’s also no shock that Boston Scientific ‘s (NYSE:BSX) shares are under-valued, with an $8.68 differential between the value of its assets per share and its share price.
Here’s how the numbers play out, ranked by differential between asset value and share price, using figures from the MassDevice Big 100 database:
You can drill down further into the data with the MassDevice Big 100 Deluxe for just $79.99, which includes in-depth interviews with some of med-tech’s most interesting CEOs.
